Global
Dr. Don Rucker, chief strategy officer for 1upHealth, discusses TEFCA going live, ONC's Health IT Certification Program, key takeaways from the final HTI-1 and how ONC's certification rule may burden both providers and vendors.
Brigid Bondoc, partner and life sciences attorney at Morrison Foerster, discusses government priorities pertaining to federal regulation of AI, where complications may arise, and concerns she has heard related to policy decisions.
Cybersecurity officers are up against well-equipped adversaries like crime syndicates, says Richard Staynings, chief security strategist at Cylera. AI can help automate and improve cybersecurity tools if adequately implemented.
Brian Esterly, CEO of TimeDoc Health, discusses health IT's role in bringing together patients and care teams and facilitating self-care management, particularly for patients with chronic conditions in healthcare deserts.
Thomas Hallisey, HANYS digital health strategy lead, discusses appropriate regulations on digital health at the state and federal levels and the need for continuous management as technology moves from automating healthcare to augmenting it.
AI is a tool to help people everywhere realize their health potential, said HIMSS Chief Scientific Research Officer Anne Snowden. If there was a time for learning, sharing and building a community of AI decision-making tools, it is now.
Steven Ullman, the University of Miami's director at the Center for Health Management and Policy, discusses telehealth use during and following the pandemic, why patient and provider satisfaction varies, and policy predictions for 2024.
As host of HIMSS AI in Healthcare Forum, Robert Havasy, senior director of the Personal Connected Health Alliance at HIMSS, discusses the cautious optimism and warnings he heard from speakers and attendees about AI technology and its progress.
Naomi Fried, founder and CEO of PharmStars, discusses the company's fifth cohort focused on solving challenges in therapeutic delivery and the 11 startups graduated from its accelerator program, including Cellular Vehicles and ZiO Health.
The American Medical Association uses “augmented intelligence,” not “artificial intelligence,” as the tech is meant to support, not replace, people, said Dr. Jesse Ehrenfeld, president of the AMA. Still, new regulatory paradigms are needed.